Sagefield Capital LP Dice Therapeutics, Inc. Transaction History

Sagefield Capital LP

  • $867 Million
  • Q2 2024

Shares

1 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2023

Aug 14, 2023
BUY
$25.86 - $46.71 $299,976 - $541,836
11,600 New
11,600 $538,000

Others Institutions Holding DICE

# of Institutions
3
Shares Held
17.7K
Call Options Held
13K
Put Options Held
0
View Full List

About DICE Therapeutics, Inc.

DICE Quotes by TradingView
  • Ticker DICE
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 46,430,000
  • Description
  • DICE Therapeutics, Inc., a biopharmaceutical company, builds various oral therapeutic candidates to treat chronic diseases in immunology and other therapeutic areas. Its platform DELSCAPE, is designed to discover selective oral small molecules to modulate protein-protein interactions (PPIs) as effectively as systemic biologics. The company's lea...
More about DICE
Track This Portfolio

Track Sagefield Capital LP Portfolio

Follow Sagefield Capital LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Sagefield Capital LP, based on Form 13F filings with the SEC.

News

Stay updated on Sagefield Capital LP with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email